SEARCH

SEARCH BY CITATION

References

  • 1
    Ferlay J,Bray F,Pisani P,Parkin DM. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, Version 1.0. IARC CancerBase No. 5. Lyon: IARC Press, 2001.
  • 2
    De Vries E,Bray F,Coebergh JWW,Parkin DM;European Network of Cancer Registers. Changing epidemiology of malignant cutaneous melanoma in Europe 1969–1997: rising trends in incidence and mortality, but recent stabilisations in Western Europe and decreases in Scandinavia. Int J Cancer 2003; 107: 11926.
  • 3
    Lens MB,Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004; 150: 17985.
  • 4
    Sáenz S,Conejo-Mir J,Cayuela A. Epidemiología del melanoma en España. Actas Dermosifiliogr 2005; 96: 41115.
  • 5
    Cayuela A,Rodriguez-Dominguez S,Lapetra-Peralta J,Conejo-Mir JS. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001 Br J Dermatol 2005; 152: 9971000.
  • 6
    Bosetti C,La Vecchia C,Naldi L,Lucchini F,Negria E,Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res 2004; 14: 3019.
  • 7
    Holford TR. Understanding the effects of age, period and cohort on incidence and mortality rates. Annu Rev Public Health 1991; 12: 42557.
  • 8
    Stang A,Jöckel KH. Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Ann Epidemiol 2003; 13: 43642.
  • 9
    Kim HJ,Fay MP,Feuer EJ,Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 33551.
  • 10
    National Cancer Institute. Joinpoint Regression Program Version 2.6, 2002. http://srab.cancer.gov/joinpoint/download.html.
  • 11
    Clayton D,Schifflers E. Models for temporal variation in cancer rates. I. Age–period and age–cohort models. Stat Med 1987; 6: 44967.
  • 12
    Clayton D,Schifflers E. Models for temporal variation in cancer rates. II. Age–period–cohort models. Stat Med 1987; 6: 46981.
  • 13
    Robertson C,Boyle P. Age, period and cohort models: the use of individual records. Stat Med 1986; 5: 52738.
  • 14
    Decarli A,La Vecchia C. Age, period and cohort models: review of knowledge and implementation in GLIM. Rev Stat Appl 1987; 20: 397409.
  • 15
    Ihaka R,Gentleman RR. R: a language for data analysis and graphics. J Comput Appl Math 1996; 5: 299314.
  • 16
    Whiteman DC,Whiteman CA,Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12: 6982.
  • 17
    Holman CD,James IR,Gattey PH,Armstrong BK. An analysis of trends in mortality from malignant melanoma of the skin in Australia. Int J Cancer 1980; 26: 7039.
  • 18
    Thorn M,Sparen P,Bergstrom R,Adami HO. Trends in mortality rates from malignant melanoma in Sweden 1953–1987 and forecasts up to 2007. Br J Cancer 1992; 66: 5637.
  • 19
    Marks R. The changing incidence and mortality of melanoma in Australia. Recent Results Cancer Res 2002; 160: 11321.
  • 20
    Stang A,Jockel KH. Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Ann Epidemiol 2003; 13: 43642.
  • 21
    Conejo-Mir JS. Campañas de prevención del melanoma. Pie 2002; 17: 45765.
  • 22
    Conejo-Mir JS,Bravo J,Díaz JL,Fernández J,Guillén C,Martí R, etal. Euromelanoma day. Results of the 2000, 2001 and 2002 campaigns in Spain. Actas Dermosifiliogr 2005; 96: 21721.
  • 23
    La Vecchia C. Sunscreens and the risk of cutaneous malignant melanoma. Eur J Cancer Prev 1999; 8: 2679.
  • 24
    Ruiz M,Cirera L,Pérez G,Borrell C,Audica C,Moreno C,Torcida I,Martos D. Comparabilidad entre la novena y la décima revisión de la Clasificación Internacional de Enfermedades aplicada a la codificación de la causa de muerte en España. Gac Sanit 2002; 16: 52632.
  • 25
    Benavides FG,Bolumar F,Peris R. Quality of death certificate in Valencia. Spain. Am J Public Health 1989; 79: 13524.
  • 26
    Doll R,Smith PG. Comparison between registries: age–standardized rates. In: WaterhouseJAH,MuirCS,ShanmugaratnamK, eds. Cancer incidence in five continents, vol. 4. IARC Scient Publ No. 42. Lyon: International Agency for Research on Cancer, 1982; 6715.
  • 27
    BerrinoF,CapocacciaR,EsteveJ, et al., eds. Survival of cancer patients in Europe: the EUROCARE-2 Study. Lyon: IARC, 1999.
  • 28
    Sant M,Aareleid T,Berrino F, et al.,the EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary. Ann Oncol 2003; 14( Suppl 5): v61v118.
  • 29
    La Vecchia C,Bosetti C. Priorities for control of malignant melanoma in Europe. Eur J Cancer Prev 2004; 13: 935.